Penalty Amount
$700,000
CRI Genetics, LLC was charged by the FTC and California Attorney General for deceptive marketing of DNA testing services, including false accuracy claims, fake reviews, and using dark patterns in billing. The company agreed to a settlement, paying a $700,000 civil penalty, and is prohibited from deceptive practices, must obtain consent for data sharing, and allow data deletion for consumers who requested it.
CRI Genetics must pay a $700,000 civil penalty, cease all deceptive marketing practices, disclose total costs and charging practices, obtain explicit consent before sharing DNA information, and delete genetic data for consumers who received refunds and requested deletion.
In-house legal teams should review customer-facing agreements (terms of service, billing authorizations, and marketing materials) and vendor/data processor agreements. Key clauses to scrutinize include: 1) representations and warranties regarding product/service accuracy and performance claims; 2) provisions governing the use and authenticity of reviews, testimonials, and endorsements; 3) billing and payment terms, especially those involving automatic renewals, negative option marketing, or 'dark pattern' design elements that could mislead consumers; 4) data processing and sharing clauses, ensuring explicit, granular consent is obtained for sharing biometric/genetic data; and 5) consumer rights sections, guaranteeing a clear, accessible mechanism for data deletion requests. Agreements may need amendments to remove unsubstantiated accuracy claims, implement unambiguous consent mechanisms for data sharing, establish a compliant data deletion process, and redesign any billing interfaces or terms that employ deceptive patterns.
Entity
CRI Genetics, LLC
Also known as: CRI Genetics
Industry
HealthcareOfficial Press Release
https://www.ftc.gov/news-events/news/press-releases/2023/11/ftc-california-obtain-order-against-dna-testing-firm-over-charges-it-made-myriad-misrepresentations
crigeneticscomplaint
https://www.ftc.gov/system/files/ftc_gov/pdf/crigeneticscomplaint.pdf
crigeneticsstipulatedorder
https://www.ftc.gov/system/files/ftc_gov/pdf/crigeneticsstipulatedorder.pdf
Federal Trade Commission Enforcement Page
https://www.ftc.gov/enforcement
"CRI Genetics, LLC (CRI)"
"$700,000 civil penalty"
"FTC Act"
"California’s Unfair Competition Law"
"False Advertising Law"
"used 'dark patterns' in its online billing process to trick consumers into paying for products they did not want and did not agree to buy"
$750K
The FTC finalized an order against Vanilla Chip LLC (doing business as TruHeight) and its principals for deceptively advertising height-enhancing supplements for children and teens without scientific evidence. The company also used fake reviews and incentivized 5-star ratings. The order requires a $750,000 payment and prohibits false health claims and deceptive review practices.
$2.3M
The FTC alleged that RentGrow, a tenant screening company, violated the Fair Credit Reporting Act (FCRA) by failing to use reasonable procedures to ensure the accuracy of its reports, including by reporting duplicate records and failing to disclose data sources. RentGrow agreed to pay a $2.25 million penalty and is prohibited from further FCRA violations and from misrepresenting dispute outcomes.
The FTC and New York Attorney General took action against Handy Technologies for deceptive earnings claims and failure to disclose fees and fines that led to millions of dollars being withheld from workers' wages. The FTC is sending over $2.7 million in refunds to 62,893 affected consumers.
$35.0M
The FTC alleged that Hopper, a travel booking app, charged consumers hidden and pre-selected fees (Tip and VIP Support) without their consent, misrepresented the benefits of VIP Support and Price Freeze services, and failed to clearly disclose total prices. Hopper agreed to pay $35 million for consumer redress and is prohibited from misrepresenting fees under a proposed order.
$1.5M
The FTC finalized a settlement with Publishing.com LLC and its principals for misleading consumers about potential earnings from self-publishing products. The company will pay $1.5 million and is prohibited from making unsubstantiated earnings claims, failing to disclose refund terms, and misrepresenting endorsements and reviews.
The FTC is seeking public comment on a proposed policy statement addressing concerns that AI companies may be manipulating AI system outputs contrary to consumer expectations for objectivity and accuracy. The statement explains that such conduct could be considered deceptive under Section 5 of the FTC Act. The public comment period runs until July 31, 2026.